Grant Number:	5R01CA075957-02 Interpret this number
Primary Investigator:	Jacobson, Lisa
Organization:	Johns Hopkins University
Project Title:	Epidemiology of Kshv and AIDS-Related Kaposis Sarcoma
Fiscal Year:	1998

DESCRIPTION (adapted from the Abstract): The goal of this study is to define the epidemiology of HIV-1 related Kaposi's sarcoma (KS) as it relates to the putative causal agent, KS herpes virus (KSHV). A proposed historical cohort study nested within the Multicenter AIDS Cohort Study (MACS), a longitudinal prospective study of the natural history of HIV-1 infection in homosexual/ bisexual men, will address these specific aims: (1) determine the prevalence and incidence of KSHV infection in this population; (2) determine the KSHV route of transmission and the concordance of characteristics associated with the virus to risk factors for KS; (3) determine rates and biological markers of progression to KS among KSHV seropositive, HIV-1 infected homosexual men and factors which may modify disease progression; (4) examine the effect of anti-retroviral and anti-herpes treatments on KS disease progression in the presence of KSHV infection; and (5) examine the health effects of KSHV in the absence of HIV-1 and the effect of KSHV on HIV-1 progression independent of its role in KS disease. Behaviors to be examined as risk factors include numbers of male sexual partners and types of sexual activities (e.g., anal/genital intercourse, anal/oral intercourse, genital/oral intercourse) and recreational drug use (e.g., nitrite inhalants). Host characteristics including age, race and immune status will be examined as effect modifiers for viral acquisition and disease progression. The effects of other environmental factors such as geographic location and co-infections will be studied, also. KSHV serological testing will be performed on selected visits for 414 HIV-1 seroconverters with known dates of seroconversion within 1 year and a stratified random sample of 400 HIV-1 seroprevalent and 100 seronegative men. KSHV seroprevalence also will be determined in a sample of injecting drug users from a cohort study with protocols similar as the MACS. Establishing the epidemiology of the KSHV, consistent with principles of causality, will provide direction for developing behavioral and therapeutic interventions against the development of KS and will guide virological and biological investigations determining the pathogenesis of this disease.




Factors Associated With Human Herpesvirus Type 8 Infection In An Injecting Drug User Cohort
Authors: Bernstein K.T. , Jacobson L.P. , Jenkins F.J. , Vlahov D. , Armenian H.K. .
Source: Sexually Transmitted Diseases, 2003 Mar; 30(3), p. 199-204.
PMID: 12616135
Related Citations

A case-control study of HIV-1-related dementia and co-infection with HHV-8.
Authors: Polk S. , Muñoz A. , Sacktor N.C. , Jenkins F.J. , Cohen B. , Miller E.N. , Jacobson L.P. .
Source: Neurology, 2002-09-24 00:00:00.0; 59(6), p. 950-3.
PMID: 12297590
Related Citations

Identification Of An Hla A*0201-restricted Cd8(+) T-cell Epitope For The Glycoprotein B Homolog Of Human Herpesvirus 8
Authors: Wang Q.J. , Huang X.L. , Rappocciolo G. , Jenkins F.J. , Hildebrand W.H. , Fan Z. , Thomas E.K. , Rinaldo C.R. .
Source: Blood, 2002-05-01 00:00:00.0; 99(9), p. 3360-6.
PMID: 11964304
Related Citations

Reactivation Of And Primary Infection With Human Herpesvirus 8 Among Solid-organ Transplant Recipients
Authors: Jenkins F.J. , Hoffman L.J. , Liegey-Dougall A. .
Source: The Journal Of Infectious Diseases, 2002-05-01 00:00:00.0; 185(9), p. 1238-43.
PMID: 12001040
Related Citations

Primary Human Herpesvirus 8 Infection Generates A Broadly Specific Cd8(+) T-cell Response To Viral Lytic Cycle Proteins
Authors: Wang Q.J. , Jenkins F.J. , Jacobson L.P. , Kingsley L.A. , Day R.D. , Zhang Z.W. , Meng Y.X. , Pellett P.E. , Kousoulas K.G. , Baghian A. , et al. .
Source: Blood, 2001-04-15 00:00:00.0; 97(8), p. 2366-73.
PMID: 11290599
Related Citations

Cd8+ Cytotoxic T Lymphocyte Responses To Lytic Proteins Of Human Herpes Virus 8 In Human Immunodeficiency Virus Type 1-infected And -uninfected Individuals
Authors: Wang Q.J. , Jenkins F.J. , Jacobson L.P. , Meng Y.X. , Pellett P.E. , Kingsley L.A. , Kousoulas K.G. , Baghian A. , Rinaldo C.R. .
Source: The Journal Of Infectious Diseases, 2000 Sep; 182(3), p. 928-32.
PMID: 10950791
Related Citations